Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

A one-piece drainage system for glaucoma surgery.

N H Joseph1, M B Sherwood, G Trantas

  • 1Moorfields Eye Hospital, Glaucoma Unit, High Holborn, London.

Transactions of the Ophthalmological Societies of the United Kingdom
|January 1, 1986
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Gastroenterologists can enhance hepatitis C screening by testing individuals referred for colorectal cancer screening.

Journal of viral hepatitis·2014
Same author

Applicability of modifications of the thin filter paper disc method to the assay of enzymes.

Journal of bacteriology·2010
Same author

The paperdisc agar-plate method for the assay of antibiotic substances.

Journal of bacteriology·2010
Same author

The utilization of thin paper discs in the assay of amylases.

Journal of bacteriology·2010
Same author

Filtration surgery as the initial therapy for open-angle glaucoma.

Journal of glaucoma·2009
Same author

Ciliochoroidal detachment after aqueous suppressant therapy.

Journal of glaucoma·2009
Same journal

Brain stem and cerebellar deficits in eye movement control.

Transactions of the ophthalmological societies of the United Kingdom·1986
Same journal

Strategies in Doppler ultrasound.

Transactions of the ophthalmological societies of the United Kingdom·1986
Same journal

Congenital glaucoma--diagnosis and management.

Transactions of the ophthalmological societies of the United Kingdom·1986
Same journal

Prostaglandins and other eicosanoids: their ocular transport, pharmacokinetics, and therapeutic effects.

Transactions of the ophthalmological societies of the United Kingdom·1986
Same journal

Development of the ciliary body: a brief review.

Transactions of the ophthalmological societies of the United Kingdom·1986
Same journal

Computer automated visual acuity testing for visual screening.

Transactions of the ophthalmological societies of the United Kingdom·1986
See all related articles

A novel one-piece aqueous humour drainage system effectively lowers intraocular pressure. This glaucoma device shows sustained pressure reduction in early clinical trials, warranting further investigation.

Area of Science:

  • Ophthalmology
  • Biomedical Engineering

Background:

  • Glaucoma is a leading cause of irreversible blindness.
  • Effective intraocular pressure (IOP) management is crucial for glaucoma treatment.
  • Current drainage devices face challenges with scar tissue formation and efficacy.

Purpose of the Study:

  • To evaluate a novel one-piece aqueous humour drainage system.
  • To assess the safety and efficacy of this device in reducing IOP.
  • To investigate the long-term performance of the device in glaucoma patients.

Main Methods:

  • A one-piece drainage system combining a tube with a pressure-limiting valve and a large silicone object was designed.
  • The device was implanted in 19 consecutive glaucoma patients at Moorfields Eye Hospital.

Related Experiment Videos

  • Intraocular pressure was measured at multiple time points post-operation (1, 2, 3, 6, and 9 months).

    • Main Results:

    • The device demonstrated successful aqueous humour drainage.
    • Average intraocular pressures remained below 18 mmHg across all follow-up periods.
    • No mention of complications related to scar tissue obstruction was noted.

    Conclusions:

    • The one-piece aqueous humour drainage system is a promising new therapeutic option for glaucoma.
    • The device achieves sustained IOP reduction, suggesting good biocompatibility and efficacy.
    • Further clinical studies are recommended to confirm these findings and assess broader applicability.